Avedro, Inc.

Equities

AVDR

US05355N1090

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.61%	-.--%

2019	Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index	CI
2019	Avedro, Inc. Announces Board Changes	CI

Avedro, Inc. Announces Board Changes

November 13, 2015 at 02:55 pm

Avedro, Inc. announced the successful completion of a $32 million equity financing led by new investors InterWest and OrbiMed which also includes several of the company's existing investors. Upon the close of the transaction, the company has reorganized its Board of Directors. The new Board will consist of new members Gil Kliman of InterWest and Jonathan Silverstein of OrbiMed along with existing Board members Joe Mandato of De Novo Ventures, Robert Palmisano, and David Muller, President and CEO of Avedro.

Latest news about Avedro, Inc.

Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index	19-11-22	CI
Avedro, Inc. Announces Board Changes	19-11-21	CI
Avedro, Inc.(NasdaqGM:AVDR) dropped from NASDAQ Composite Index	19-11-21	CI
Glaukos Corporation completed the acquisition of Avedro, Inc. from a group of sellers.	19-11-20	CI
Avedro, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-06	CI
Certain Common Stock of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	19-08-12	CI
Certain Options of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	19-08-12	CI
Certain Warrants of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	19-08-12	CI
Certain Restricted Stock Units of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	19-08-12	CI
Avedro, Inc. Announces Resignation of Thomas W. Burns and Gilbert H. Kliman from the Board of Directors	19-08-07	CI
Avedro, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019	19-08-07	CI
Glaukos Corporation entered into a definitive merger agreement to acquire Avedro, Inc. from a group of sellers for approximately $490 million.	19-08-06	CI
Avedro, Inc.(NasdaqGM:AVDR) added to Russell 2000 Dynamic Index	19-06-28	CI
Avedro, Inc.(NasdaqGM:AVDR) added to S&P TMI Index	19-06-24	CI
Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM	19-05-14
Transcript : Avedro, Inc., Q1 2019 Earnings Call, May 09, 2019	19-05-09
Avedro, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019	19-05-09	CI
Transcript : Avedro, Inc., Q4 2018 Earnings Call, Mar 21, 2019	19-03-21
Avedro, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2018; Provides Revenue Guidance for the Full Year of 2019	19-03-21	CI
Avedro, Inc.(NasdaqGM:AVDR) added to NASDAQ Composite Index	19-02-15	CI
Avedro, Inc. has completed an IPO in the amount of $70 million.	19-02-13	CI
Avedro, Inc. has filed an IPO in the amount of $86.25 million.	19-01-18	CI
Avedro To Seek Acquisition	19-01-18	CI
Avedro, Inc. Auditor Raises 'Going Concern' Doubt	18-12-20	CI
Avedro, Inc. Announces That Permanent J Code Issued for Avedro’S Photrexa® Drug Formulations	18-11-20	CI

Chart Avedro, Inc.

Duration

Period

More charts

Company Profile

Avedro Inc is a United States-based company. The Company is an ophthalmic pharmaceutical and medical device company developing and commercializing a suite of products based on its corneal collagen cross-linking technology platform to address a wide variety of ophthalmic disorders and conditions, primarily associated with corneal weakness. Its primary components of the Avedro Cross-Linking Platform are pharmaceutical formulations of riboflavin (vitamin B2), a âsingle dose pharmaceutical,â sold primarily in conjunction with the Companyâs innovative devices for the delivery of metered doses of ultraviolet (UVA) light, a medical device.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AVEDRO, INC.	-.--%	403M
ABBOTT LABORATORIES	-2.26%	187B
MEDTRONIC PLC	+2.05%	110B
BECTON, DICKINSON AND COMPANY	-1.31%	69.54B
CENCORA, INC.	+14.65%	46.37B
DEXCOM, INC.	-6.69%	46.05B
HOYA CORPORATION	+7.97%	42.54B
METTLER-TOLEDO INTERNATIONAL, INC.	+18.60%	30.72B
TERUMO CORPORATION	+16.92%	25.62B
ZIMMER BIOMET HOLDINGS, INC.	-6.87%	23.32B

Other Medical Equipment, Supplies & Distribution